- Home
- ALDX vs GHI Comparison
ALDX vs GHI Comparison
Compare ALDX & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALDX | GHI |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.9M | 121.3M |
| IPO Year | 2014 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ALDX | GHI |
|---|---|---|
| Price | $2.28 | $5.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.50 | ★ $10.50 |
| AVG Volume (30 Days) | ★ 1.8M | 63.1K |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 22.93% |
| EPS Growth | ★ 40.43 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $85,389,766.00 |
| Revenue This Year | N/A | $273.95 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $596.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.07 | $4.71 |
| 52 Week High | $6.18 | $11.58 |
Technical Indicators
Market Signals| Indicator | ALDX | GHI |
|---|---|---|
| Relative Strength Index (RSI) | 64.42 | 64.74 |
| Support Level | $1.49 | $5.05 |
| Resistance Level | $5.73 | $6.16 |
| Average True Range (ATR) | 0.19 | 0.24 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 68.86 | 80.58 |
Price Performance
Historical ComparisonAbout ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.